EGF and glioblastoma: Moreover, several studies have demonstrated that primary patient-derived (PD)-GSCs, cultured in serum-free neurobasal medium, supplemented with epidermal growth factor (EGF) and fibroblast growth factor (FGF), are more representative of the tumor than traditional, commercially available GBM cell lines [22,38,39].